Source: ALL
Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gilbert Disease (disorder)
|
29 | 0.701 | 0.440 | 2 | 233760498 | missense variant | G/A | snv | 2.2E-02 | 9.2E-03 | 0.800 | 1.000 | 15 | 1995 | 2018 | ||||
Bilirubin measurement
|
535 | 0.701 | 0.440 | 2 | 233760498 | missense variant | G/A | snv | 2.2E-02 | 9.2E-03 | 0.800 | 1.000 | 2 | 2010 | 2013 | ||||
Crigler Najjar syndrome, type 2
|
27 | 0.701 | 0.440 | 2 | 233760498 | missense variant | G/A | snv | 2.2E-02 | 9.2E-03 | 0.750 | 1.000 | 20 | 1993 | 2018 | ||||
Bilirubin level result
|
478 | 0.701 | 0.440 | 2 | 233760498 | missense variant | G/A | snv | 2.2E-02 | 9.2E-03 | 0.700 | 1.000 | 1 | 2013 | 2013 | ||||
Height
|
517 | 0.701 | 0.440 | 2 | 233760498 | missense variant | G/A | snv | 2.2E-02 | 9.2E-03 | 0.700 | 1.000 | 1 | 2010 | 2010 | ||||
Lucey-Driscoll syndrome (disorder)
|
4 | 0.701 | 0.440 | 2 | 233760498 | missense variant | G/A | snv | 2.2E-02 | 9.2E-03 | 0.700 | 1.000 | 1 | 2000 | 2000 | ||||
Hyperbilirubinemia
|
27 | 0.701 | 0.440 | 2 | 233760498 | missense variant | G/A | snv | 2.2E-02 | 9.2E-03 | 0.100 | 0.923 | 13 | 2001 | 2019 | ||||
Hyperbilirubinemia, Neonatal
|
15 | 0.701 | 0.440 | 2 | 233760498 | missense variant | G/A | snv | 2.2E-02 | 9.2E-03 | 0.100 | 1.000 | 10 | 2007 | 2019 | ||||
Neonatal Jaundice
|
2 | 0.701 | 0.440 | 2 | 233760498 | missense variant | G/A | snv | 2.2E-02 | 9.2E-03 | 0.030 | 1.000 | 3 | 2007 | 2011 | ||||
ABO incompatibility
|
2 | 0.701 | 0.440 | 2 | 233760498 | missense variant | G/A | snv | 2.2E-02 | 9.2E-03 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Breast Carcinoma
|
2793 | 0.701 | 0.440 | 2 | 233760498 | missense variant | G/A | snv | 2.2E-02 | 9.2E-03 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Carcinoma of larynx
|
65 | 0.701 | 0.440 | 2 | 233760498 | missense variant | G/A | snv | 2.2E-02 | 9.2E-03 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Cholelithiasis
|
90 | 0.701 | 0.440 | 2 | 233760498 | missense variant | G/A | snv | 2.2E-02 | 9.2E-03 | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||
Colorectal Carcinoma
|
1962 | 0.701 | 0.440 | 2 | 233760498 | missense variant | G/A | snv | 2.2E-02 | 9.2E-03 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Drug-Induced Liver Disease
|
29 | 0.701 | 0.440 | 2 | 233760498 | missense variant | G/A | snv | 2.2E-02 | 9.2E-03 | 0.010 | 1 | 2019 | 2019 | |||||
Hemolytic disease of fetus OR newborn due to ABO immunization
|
1 | 0.701 | 0.440 | 2 | 233760498 | missense variant | G/A | snv | 2.2E-02 | 9.2E-03 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Icterus
|
17 | 0.701 | 0.440 | 2 | 233760498 | missense variant | G/A | snv | 2.2E-02 | 9.2E-03 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Malignant neoplasm of breast
|
3417 | 0.701 | 0.440 | 2 | 233760498 | missense variant | G/A | snv | 2.2E-02 | 9.2E-03 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Malignant neoplasm of larynx
|
50 | 0.701 | 0.440 | 2 | 233760498 | missense variant | G/A | snv | 2.2E-02 | 9.2E-03 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Secondary malignant neoplasm of colon and/or rectum
|
68 | 0.701 | 0.440 | 2 | 233760498 | missense variant | G/A | snv | 2.2E-02 | 9.2E-03 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
UGT1A1 gene polymorphism
|
1 | 0.701 | 0.440 | 2 | 233760498 | missense variant | G/A | snv | 2.2E-02 | 9.2E-03 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Unconjugated hyperbilirubinemia
|
4 | 0.701 | 0.440 | 2 | 233760498 | missense variant | G/A | snv | 2.2E-02 | 9.2E-03 | 0.010 | 1.000 | 1 | 2016 | 2016 |